Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for Intimation Of Board Meeting Of The Company Scheduled To Be Held On 11Th November, 2020

 Earum Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2020 ,inter alia, to consider and approve We hereby inform you that, pursuant to Regulation 29 of the securities and Exchange board of India (Listing obligations and disclosures Requirements) Regulations, 2015, a meeting of the Board of Directors of the company scheduled to be held on Wednesday, 11th November, 2020 at 04:00 PM at the Corporate Office Of The Company Situated At A-1106, Empire Business Hub, Near Auda Water Tank, Science City Road, Sola, Ahmedabad, Gujarat - 380060, inter alia to transact the following business: 1. To Consider and approve the unaudited financial results of the company for the half year ended as on 30th September, 2020. 2. To review the operations of the company, and 3. Any other business that may deem necessary with the permission of the chair
04-11-2020
Bigul

Earum Pharmaceuticals Ltd - 542724 - Closure of Trading Window

 Pursuant to SEBI (Prohibition of Insider Trading) Regulation 2015, we wish to inform you that the Trading Window for dealing in securities of the company shall remain closed with effect from Thursday, October 1, 2020 till 48 hours after the announcement of the unaudited financial results of the company for the half year ended on September 30, 2020.
02-10-2020
Bigul

Earum Pharmaceuticals Ltd - 542724 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to the requirement of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, we hereby enclose the certificate received from our Share Transfer Agent viz. Bigshare Services Private Limited for the quarter ended on 30th June, 2020.
22-07-2020
Bigul

Earum Pharmaceuticals Ltd - 542724 - Statement Of Investor Complaints For The Quarter Ended June 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- RONAK NARENDRA LALWANIDesignation :- Company Secretary and Compliance Officer
22-07-2020
Bigul

Earum Pharmaceuticals Ltd - 542724 - Revised Audited Financial Result For The Quarter And Financial Year Ended 31St March, 2020 Under Regulation 33 Of SEBI (LODR), 2015

 This has with reference to our submission, inadvertently the date of signing of Financial Statements by Auditor typed 22.06.2020 instead of 30.06.2020. We would like to bring this in your kind notice that it was a typing mistake and there was no mala-fide intension behind this. We are hereby submitting the revised Financial Statements for the Quarter and Year ended on 31st Day of March, 2020 with the correct date of Signing. You are hereby requested to take this on record and acknowledge the same.
01-07-2020
Bigul

Earum Pharmaceuticals Ltd - 542724 - Audited Financial Result For The Quarter And Financial Year Ended 31St March, 2020 Under Regulation 33 Of SEBI (LODR), 2015

 We wish to inform that the Board of Directors of the Company at its meeting held on Tuesday, 30th June, 2020 has considered and approved the Audited Financial Results of the Company for the Quarter and Financial Year ended 31st March, 2020. Further, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are enclosing herewith following: 1. Audited Financial Results for the Quarter and Financial Year ended 31st March, 2020; 2. Auditor's Report on Audited Financial Results for the Quarter and Financial Year ended 31st March, 2020. 3. A declaration pursuant to Regulation 33(3) of the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2016 read with the Circular issued by the SEBI vide No. CIR/CFD/CMD/56/2016 dated May 27, 2016.
30-06-2020
Bigul

Earum Pharmaceuticals Ltd - 542724 - Board Meeting Intimation for Notice Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) 2015

 Earum Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2020 ,inter alia, to consider and approve Approval of Audited Financial Results of the Company for the Quarter and Financial Year ended on 31st March, 2020. Further in accordance with our intimation dated April 1, 2020 regarding Code of Conduct to Regulate, Monitor and Report Trading by Insiders of the Company pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, the "Trading Window" for trading / dealing in the securities of the Company shall remain closed from April 01, 2020 to July 02, 2020 (both days inclusive).
24-06-2020
Bigul

Earum Pharmaceuticals Ltd - 542724 - Intimation For Introduce Wide Range Of Hand Sanitizer In Liquid And Gel Base And Antiseptic Disinfectant Product Range To Fight Against COVID-19

 This is to inform you that the Company has started Production of wide range of Hand Sanitizer in liquid and Gel base and Antiseptic Disinfectant Product Range to fight against COVID-19 at its unit.
05-05-2020
Bigul

Earum Pharmaceuticals Ltd - 542724 - Compliance Certificate Pursuant To Regulation 7 (3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended As On 31St March, 2020.

 Further, in compliance with the provision of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the certificate for the half year ended 31st March, 2020 i.e. for the period from 01st October, 2019 to 31st March, 2020.
04-05-2020
Bigul

Earum Pharmaceuticals Ltd - 542724 - Compliance Certificate In Terms Of Regulation 40(9) Of SEBI (Listing And Obligations Requirements) Regulations, 2015 For The Half Year Ended On 31St March, 2020

 Find herewith attached Certificate under Regulation 40(9) of SEBI (Listing and Obligations Requirements) Regulations, 2015 for the half year ended on 31st March, 2020 issued by Bigshare Services Private Limited. Registrar and Share Transfer Agent (RTA) and Mr. Hardik Joshi, Practicing Company Secretary, Ahmedabad.
28-04-2020
Next Page
Close

Let's Open Free Demat Account